Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |